Abstract Submission

You can prepare your abstract(s) in this section and edit them until you submit your abstract(s) for review to the Scientific Committee.

Please carefully read the abstract guidelines;

Abstract Submission Starts 21 December 2012
Abstract Submission Ends 28 January 2013
Abstract Acceptance Announcements 08 February 2013
Registration Deadline for Accepted Abstract Authors 20 February 2013
Final Program Announcement 15 February 2013

Authors can submit abstracts related with "Obstructive Airway Diseases", for e-poster discussion only (no oral presentation will be accepted) for COPD ISTANBUL. All abstracts must be prepared in Turkish or English. Abstracts will be accepted only through the "Online Abstract System" on our website by January 25, 2013. Abstracts sent through e-mail, fax, ordinary post or delivered by hand will not be evaluated. Please carefully check all text for errors before submitting into the system as the quality of your submission may strongly affect the outcome of the reviewer's scoring of your abstract.

Online Abstract System Procedure

  • Authors shall open an account on the online abstract system with a username and a password.
  • Please do not forget to authorize your abstract once submitted. Only authorized abstracts will be evaluated. Abstracts not authorized by the authors will not be submitted to referees.

Abstract Submission Rules

  • The abstract should not be longer than 250 words.
  • The title must be less than 10 words and express the essence of the study.
  • Names, last names, titles, institutions, cities and contact details of the authors should be stated clearly.
  • Presenting author should be stated in the system.
  • Abstract body should not include any indication of the authors’ personal details.
  • Avoid reference to institution names, locations, or funding sources in the text of the abstract.
  • The abstract (excluding case reports) should  include the fullowing sections:
  • Purpose: In one brief sentence, provide the rational for the investigation and/or the question to be answered, with or without short citation(s). Citations should be listed and provide the name and initials of authors (max 3), title of article, title of journal, year of publication, the vulume number and first and last page numbers in full. Please note: The aim implies that case reports cannot be accepted unless the case has considerable clinical significance that deserves presentation.

Materials and methods: The experimental conditions should be reported briefly (i.e. age group, nature of the subjects, gender). The clinical approach and study period should be precisely described. The methods used should also be clearly indicated (i.e. image analysis, biochemical data, histulogical, immunohistulogical or mulecular probes used for the analysis of the data, statistical significance).

Results: The main results of the study should be stated briefly.

Conclusions: This is any conclusion(s) that can be drawn from the results.
This final statement is crucial because it supports the scientific value of the presentation.

  • Abstracts of the unfinished studies will not be evaluated.
  • Tables, charts or graphics should not be included in the abstract.

Evaluation Criteria
The evaluation by the reviewers is based on; Scientific or Clinical interest in the question to be assessed sufficient data providedInnovation Clinical impact

Acceptance Announcement

  • Abstract acceptance letters will be sent by January 28th , 2013.
  • Abstract acceptance letters will be sent to the submitting authors contact e-mail address in the system.
  • All accepted abstracts will be highlighted in the system and authors will be able to monitor the actual situation of their abstracts.
  • At least 1 of the authors of each accepted abstract shall register before February 8th, 2013, in order to include their abstract in the final scientific program.


  • At "COPD ISTANBUL", we will be using e-posters instead of conventional printed posters. We are using e-posters to reduce carbon footprint and to save on the costs associated with printing and laminating a conventional poster.
  • What is an E-Poster? An e-poster is an electronic version of the traditional boards, and is displayed on monitor screens. The e-poster may include text, figures and images, as well as video.
  • When can I view a specific poster? A specific poster can be viewed any time during the Conference. A specific time slot will not be required. Simply use one of the computers located in the e-poster area at a time convenient to you. You will be able to view all electronic posters as frequently, and as often as you wish.
Fullowing Submission: You will receive more information by email. For assistance, please contact the Secretariat.